Gw Henssler & Associates LTD Aerie Pharmaceuticals Inc Transaction History

Gw Henssler & Associates LTD

  • $1.76 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$33.0 - $60.04 $179,025 - $325,717
-5,425 Closed
0 $0
Q3 2018

Oct 23, 2018
BUY
$56.15 - $73.9 $304,613 - $400,907
5,425 New
5,425 $334,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Gw Henssler & Associates LTD Portfolio

Follow Gw Henssler & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email